Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

4 months ago 12
Read Entire Article
  1. Homepage
  2. Finance
  3. Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

Related

Bayview Acquisition Corp receives Nasdaq notice for minimum market value deficiency

Bayview Acquisition Corp receives Nasdaq notice for minimum ...

58 minutes ago 0
Mid Penn Bancorp updates executive retirement and change in control agreements

Mid Penn Bancorp updates executive retirement and change in ...

58 minutes ago 0
Form 13G Adagio Medical Holdings For: 26 August

Form 13G Adagio Medical Holdings For: 26 August

58 minutes ago 0

Trending

1. sorana cirstea
2. jesus piece
3. juju brents
4. ravens 53 man roster
5. tsitsipas
6. pafos fc
7. chris paul jr
8. carlos santana mlb
9. darius cooper
10. cole strange

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

7 months ago 481
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 236
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 196
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

5 months ago 190
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 185
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved